Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in vivo atherosclerosis imaging (Q47851250)

6 February 2018

title

Feasibility and kinetic characteristics of (68)Ga-NOTA-RGD PET for in vivo atherosclerosis imaging (English)

1 reference

6 February 2018

1 reference

6

June-Key Chung

1 reference

6 February 2018

author name string

Jin Chul Paeng

1

1 reference

6 February 2018

Yun-Sang Lee

2

1 reference

6 February 2018

Jae Sung Lee

3

1 reference

6 February 2018

Jae Min Jeong

4

1 reference

6 February 2018

Ki-Bong Kim

5

1 reference

6 February 2018

Dong Soo Lee

7

1 reference

6 February 2018

publication date

6 August 2013

1 reference

6 February 2018

Annals of Nuclear Medicine

published in

1 reference

6 February 2018

volume

27

1 reference

6 February 2018

issue

9

1 reference

6 February 2018

page(s)

847-854

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s12149-013-0757-x

exact match

0 references

cites work

Imaging of atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography. Pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Molecular imaging of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

68Ga-DOTA-RGD peptide: biodistribution and binding into atherosclerotic plaques in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with 18F-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12149-013-0757-X

10.1007/S12149-013-0757-X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

23918450

1 reference

6 February 2018